Skip to search formSkip to main contentSkip to account menu

cytotoxic drug

Known as: cytotoxic agent, agent cytotoxic, agents cytotoxic 
National Institutes of Health

Related topics

Related topics

2 relations
Antineoplastic AgentsCytotoxin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Regulatory verification on safe use of cytotoxic drugs in veterinary clinics and animal hospitals.
BACKGROUND Veterinarians are increasingly being asked to provide chemotherapy for veterinary patients. However, chemotherapy… 
2016
2016
Comparing QUS parameters to structural and functional changes in tumors during therapy
Tumor microstructure can potentially be evaluated with quantitative ultrasound (QUS) during therapy, but parameters are… 
2015
2015
Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice
The objective of this study was to determine the effect of anti-gastrin antiserum in combination with varied dosages of cytotoxic… 
Review
2013
Review
2013
TCH-004 Centralization and Technology Support the Hospital Pharmacist in Improving Safety, Accuracy and Economy in the Management of Monoclonal Antibodies
Background Antineoplastic drugs are considered ‘high-risk drugs’ due to the increased frequency of human technical errors in… 
2012
2012
Protection available to resident doctors in a suburban Nigerian Teaching Hospital against exposure to cytotoxic drugs
SUMMARY Cytotoxic drugs (CDs) are used commonly in the management of malignant diseases; they act by inhibiting growth and kill… 
2011
2011
[Determination of airborne and surface contamination with cyclophosphamide at the Masaryk Memorial Cancer Institute, Brno, Czech Republic].
Manipulation with cytotoxic drugs (CDs) during the preparation and administration of chemotherapy to cancer patients can… 
2010
2010
Retreatment with trastuzumab after progression on lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: A monoinstitutional experience.
1082 Background: Continuing trastuzumab (T) in association with a different cytotoxic agent (CA) is a common practice in… 
2010
2010
Lapatinib plus capecitabine in highly pretreated HER2-positive metastatic breast cancer: A single-institution experience.
1145 Background: Therapies targeting HER2 are very effective in metastatic breast cancer (MBC) combined with chemotherapeutic… 
2005
2005
Synthesis and biological evaluation of a paclitaxel immunoconjugate.
Targeted cancer therapy is a promising strategy for the treatment of this disease. In this approach, a cytotoxic agent (CA), such… 
1987
1987
Guidelines for the Preparation, Administration, and Disposal of Cytotoxic Drugs.
Abstract : This technical guide presents current guidance for the preparation, administration, and disposal of cytotoxic drugs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)